Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

BIZARRE: This analyst just upgraded resmed stock heres why | Mind Blowing Facts

ResMed (RMD) shares are pushing higher on Tuesday after a senior RBC Capital Markets analyst upgraded the medical equipment specialist to an “Outperform” rating. In his research note, Craig Wong-Pan cited RMD’s robust Q4 performance as he lifted his price target as well to $262, indicating potential upside of nearly 10% from here.

Note that ResMed stock has already been in a massive uptrend in recent months, currently trading about 28% above its June low.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.